Anthropometric Variables Accurately Predict Dual Energy X-Ray Absorptiometric-Derived Body Composition and Can Be Used to Screen for Diabetes by Yavari, Reza et al.
Anthropometric Variables Accurately Predict Dual
Energy X-Ray Absorptiometric-Derived Body
Composition and Can Be Used to Screen for Diabetes
Reza Yavari
1,2, Erin McEntee
3, Michael McEntee
4, Michael Brines
5*
1Beyond Care, LLC, Guilford, Connecticut, United States of America, 2Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut,
United States of America, 3Physician Assistant Program, School of Medicine and Health Sciences, The George Washington University, Washington, D.C., United States of
America, 4Impact Health Biometric Testing, Inc., King of Prussia, Pennsylvania, United States of America, 5Research and Development, The Kenneth S. Warren Institute,
Ossining, New York, United States of America
Abstract
The current world-wide epidemic of obesity has stimulated interest in developing simple screening methods to
identify individuals with undiagnosed diabetes mellitus type 2 (DM2) or metabolic syndrome (MS). Prior work utilizing
body composition obtained by sophisticated technology has shown that the ratio of abdominal fat to total fat is a
good predictor for DM2 or MS. The goals of this study were to determine how well simple anthropometric variables
predict the fat mass distribution as determined by dual energy x-ray absorptometry (DXA), and whether these are
useful to screen for DM2 or MS within a population. To accomplish this, the body composition of 341 females
spanning a wide range of body mass indices and with a 23% prevalence of DM2 and MS was determined using DXA.
Stepwise linear regression models incorporating age, weight, height, waistline, and hipline predicted DXA body
composition (i.e., fat mass, trunk fat, fat free mass, and total mass) with good accuracy. Using body composition as
independent variables, nominal logistic regression was then performed to estimate the probability of DM2. The
results show good discrimination with the receiver operating characteristic (ROC) having an area under the curve
(AUC) of 0.78. The anthropometrically-derived body composition equations derived from the full DXA study group
were then applied to a group of 1153 female patients selected from a general endocrinology practice. Similar to the
smaller study group, the ROC from logistical regression using body composition had an AUC of 0.81 for the detection
of DM2. These results are superior to screening based on questionnaires and compare favorably with published data
derived from invasive testing, e.g., hemoglobin A1c. This anthropometric approach offers promise for the
development of simple, inexpensive, non-invasive screening to identify individuals with metabolic dysfunction within
large populations.
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Introduction
Currently, a pandemic of obesity exists that is associated with a
number of serious and debilitating diseases, including diabetes
mellitus type 2 (DM2) and metabolic syndrome (MS), a condition
which is characterized by central obesity, glucose intolerance,
hypertension, and hyperlipidemia [1]. The economic, cultural,
and personal costs of these conditions are extremely high and are
projected to grow rapidly in the future. For example, currently
about 25% of North Americans have MS [2] and its presence
doubles the risk of adverse cardiovascular outcomes [3]. Further,
results of a number of prospective studies show that identification
of individuals at high risk for metabolic disease allows for direct life
style or medical interventions that delay or prevent the progression
of DM2 [4,5] and MS [6,7]. However, to date reliable
identification of individuals with undiagnosed metabolic dysfunc-
tion within a population has required invasive blood sample
collection and laboratory testing, e.g., fasting serum glucose
concentrations, oral glucose tolerance testing (OGTT), or
hemoglobin A1c determination. Clearly, because the prevalence
of DM2 and MS within large populations in the developed and
developing world countries is so high, there is a need for simple,
effective screening methods to identify those individuals who likely
have disease. Those at high risk could then be offered follow-up
diagnostic testing to determine definitively the degree of metabolic
dysfunction and offered appropriate treatments.
There has been an intense interest focused on the potential
pathophysiologic pathway(s) by which obesity causes disease. Notably,
the mere presence of obesity is not a sensitive measure of risk for
metabolic dysfunction, as an appreciable number of obese individuals
within a population do not currently have disease, and furthermore,
will not progress into a prediabetic state. Abundant research effort has
focused on identifying what specific aspects of obesity are important
predictors of the eventual development of cardiometabolic risk. One
promising lead has focused on the pattern of regional fat distribution.
On the basis of abundant investigational work, waist circumference
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24017[8] and intra-abdominal (i.e., trunk or visceral) fat have been identified
to be important predictors of disease [9], and the latter is also
hypothesized to be a direct cause of the development of a glucose
intolerance and frank diabetes. Notably, individuals with increased
central fat depots have increased circulating levels of proinflammatory
cytokines and other inflammatory molecules (e.g., C-reactive protein)
that are associated with insulin resistance, cardiovascular disease, lipid
abnormalities, and hypertension.
From the perspective of public health screening for individuals at
risk for metabolic disease, estimation of body fat distribution using
the available methods to accurately determine body composition,
i.e., computerized tomography, magnetic resonance imaging, or
dual energy x-ray absorptometry (DXA), are generally impractical
for field use. It is therefore desirable to have available simple
methods that can accurately estimate body composition. With
respect to this need, it is obvious that the body shape and size of
individual humans are more similar than different. It is also logical
to assume that as weight increases with the deposition of fat, muscle
massmustincrease proportionally to effectively support incremental
increases in weight. It is likely, therefore, that fat mass (FM) and fat
free mass (FFM) depend upon weight in a predictable manner.
Several investigators employing isotopic dilution methodology have
studied subjects of a wide range of body masses to determine how
body composition varies with weight. The results show that a
predictable mathematical relationship exists such that FFM is
proportionaltologarithm ofFM[10,11].However,thesestudiesdid
not take into account regional differences of fat deposition, which
are likely important as trunk fat is specifically associated with lean
muscle mass, due in part to the effects of gravity [12].
Abundant previous work that has also shown that body
composition as determined by isotope dilution or hydrological
methods to determine body density, i.e., FM and FFM, can be
reasonably estimated by anthropometrics over a wide range of
body mass in both restricted [13] and generalized populations
[14]. In recent years, the development of DXA has allowed for
rapid determinations of body composition with a high precision
comparable to the results of hydrostatic weighing, and DXA
methodology also accurately determines the proportion of
abdominal fat to total fat [15,16]. We therefore postulated that
simple anthropometric variables can predict the regional distribu-
tion of fat and lean tissue masses as determined by DXA. To
explore this possibility, we modeled DXA-derived data obtained
by a single investigator using anthropometric variables obtained
from a group of 341 females spanning a broad range of body
shapes and weights. This group was split into two unequal smaller
groups and multiple linear regression performed on the larger
subset to develop equations that related anthropometric variables
to DXA-obtained body composition. The subsequent equations
were then tested in a smaller group for cross-validation.
Additionally, since DXA body composition obtained from a
longitudinal study of a typical population of North American
females can be used to assess risk that an individual will eventually
develop DM2 [17], we hypothesized that anthropometrically-
determined body composition in the same study group can be used
to screen a population to detect individuals at high risk for having
DM2 or MS. Finally, we used the predictive equations derived from
the DXA study group to determine whether the same equations
would predict the presence of DM2 and MS in a different group of
females selected from a general endocrinology practice (n=1153).
Results
As summarized in Table 1, the study groups were well-matched,
spanning a wide range of fat masses from very lean to morbidly
obese. Although the prevalence of DM2 was significantly lower in
the Index Group (IG; 5%), it was equivalent in the cross validation
(CV) and endocrine practice (EP) groups at 13% and 10%
respectively. The prevalence of MS did not differ across the
groups, ranging from 19% in the EP group to 26% in the CV
group. Linear correlations between the anthropometric variables
and the DXA-derived body compartments or weight of all women
undergoing DXA scanning (IG+CV=341) are summarized in
Tables 2 and 3. Not surprisingly, weight was significantly and
strongly correlated with hipline and waistline, moderately with
height, but not with age (Table 2). Partial correlations were
calculated to estimate the linear association between pairs of
variables, i.e., by holding all other variables constant. Partial
correlation analysis revealed that waistline had highest correlation
with weight. Interestingly, correlations between anthropometric
variables and DXA-derived body compartments showed that
waistline was not correlated to the total fat mass, but rather to TF
and to FFM (Table 2). Although hipline was strongly correlated to
FM, TF, and FFM, partial correlation showed that the
relationship actually depended on other variables, as the
correlation vanished for TF and FFM. As expected, age was only
correlated with FFM, which was in an inverse manner.
Stepwise multiple regression analysis performed on the Index
Group relating the independent anthropometric variables to
DXA-derived body composition revealed that significant regres-
sors were age, height, weight, waistline and hipline for FM and
FFM, while age, height, weight, and waistline were regressors for
TF. These multiple linear regression models predicted the DXA
body compartment masses with reasonable precision, as the actual
DXA-derived FM and that predicted by the regression model
based on anthropomorphic variables were characterized by a
mean bias (i.e., actual mass-predicted mass) of 0.281 kg. The
accuracy of model estimates for other body compartments were
similar (Figure 1B–C), with TF and FFM having mean biases of
0.328 and 20.176 kg respectively. Total body mass (FM + FFM)
was extremely well predicted with a mean bias of 0.672 kg and the
limits of agreement, i.e., the range over which the difference
between the two measurements will fall 95% of the time, was
about 3.3 kg (Figure 1D). Notably, unlike the other variables, the
bias of the predicted total mass increased with increasing total
weight, reaching a maximum of ,2 kg for weights greater than
100 kg.
The relationships between anthropometrically-predicted body
composition (regression equations tabulated in Table 4) and
weight was explored further. Total weight, as calculated using
predicted FM + predicted FFM, matched the actual mass with
high accuracy, with the linear regression equation of: DXA
weight=0.63+0.996predicted weight (r
2=0.99; Figure 2). The
contribution of FM and FFM to weight was in a ratio of 0.59
to 0.37, with regression equations FM=0.596weight216.5
(r
2=0.98) and FFM=0.376weight+18.7 (r
2=0.961). Trunk fat
was related to weight in a 0.32 to 1 ratio (TF=0.326weight211.1;
r
2=0.96; Figure 2 D). FFM versus FM was therefore linear with a
slope of 0.59 (Figure 3A). The different slopes of the FM and FFM
relationships with weight showed that a limiting ratio of
approximately 1 was obtained for high body masses (Figure 3B).
The relationship between FM and FFM is summarized by the
equation: FFM/FM=12.89(exp
2(0.046weight))+1.06.
The equations derived from the linear models of body
composition of the IG (predicted FM, TF, and FFM) was
subsequently applied to the Cross-Validation population. The
means of the predicted values did not differ significantly from
actual measurements when compared to the IG (Table 5),
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independent test population.
Stepwise nominal logistic regression analysis was then per-
formed using the full data set (IG + CV; n=341) to determine the
probability of an individual diagnosed with DM2 based upon
DXA derived body composition. Although FM and TF were
highly significant contributing independent variables, FFM was
not a significant regressor in this model. The receiver operator
characteristic curve (ROC; Figure 4A) constructed using nominal
logistic regression exhibited an area under the curve (AUC) of
0.7860.05 (95% confidence interval 0.68–0.88; p,0.0001). This
curve is notable for a steep initial slope of ,4 (i.e., four times more
true positives than false positives identified as the nominal logistic
model threshold for a positive diagnosis was reduced) until about
60% of the true positives with a corresponding 15% false positive
rate, and was about 0.5 thereafter. Similar to the logistic model
estimating the probability of DM2 within the study group, the
predictive model of either DM2 or MS within the group depended
upon only FM and TF as significant regressors. However, the
AUC of the ROC (Figure 4B) was lower at 0.71+0.03 (0.64–0.77;
p,0.0001). Like the previous model screening for DM2 alone, the
ROC of the model corresponding the presence of either DM2 or
MS has a steep initial slope of ,3.3 to the point 40% true positives
and 12% false positives and thereafter reduced to ,1 until the
80% of true positives are correctly diagnosed.
A final regression model of body composition was derived using
the full data set (IG + CV) with height, age, weight, waistline, and
hipline as independent variables. This model was then used to
estimate body composition (i.e., FM, TF, and FFM) of a group of
females who were a subset of the population of a general
endocrinology practice (n=1135). Nominal logistic regression was
performed using predicted FM, TM, and FFM to determine the
probability that an individual within the population had metabolic
dysfunction. Unlike the smaller DXA group studied, FFM was a
significant regressor within the EP population. These analyses
produced similar appearing ROCs when compared to the smaller
DXA data set. With respect to the probability of the presence of
DM2, the ROC (Figure 5A) had an AUC of 0.8060.02 (0.76–
0.84; p,0.0001). Notably, this curve has three inflection points.
An initial slope of ,5.6 up to 28% True Positive (TP) and 5%
False Positive (FP). Thereafter, the slope decreased to ,2.5 until
85% TP and 35% FP. Nominal logistic regression for the
probability of DM2 or MS produced an ROC (Figure 5B) with
an AUC of 0.8160.01 (0.78–0.84; p,0.0001). This curve also had
a triphasic slope: up to ,18% TP was associated with a very low
rate of FP (0.1%), a slope of ,18. Thereafter, the slope decreased
to ,2.0 until 90% TP and 35% FP.
Discussion
In the present work, we have shown that in an obese female
population, anthropometric linear regression models predict the
DXA-determined body compartments FM, TF, and FFM with
good accuracy. Further, the distribution of body fat, as determined
by DXA or the anthropometric models, can be used to identify a
majority of individuals with a high probability of a formal
diagnosis of DM2 or MS with a low false positive rate. To
accomplish these, an Index Group was initially studied and the
linear models generated were then validated using a similar cross-
validation population. A final linear model was derived using data
of the full DXA group (IG + CV) and subsequently applied to a
Table 1. Characteristics of the study populations.
group (n) IG (246) CV (95) EP (1153)
Age [Mean 6 SD] (Range) 47.7611.7 (15–73) 46.1612.1 (16–67) 46.2611.6 (18–80)
Weight (kg) 85.2619.2 (42.2–146.2) 86.0620.7 (45.3–131.6) 87.8622.2 (43.1–190.5)
Height (m) 1.6160.08 (1.27–1.83) 1.6260.07 (1.24–1.8) 1.6360.08 (1.35–1.92)
DXA FFM (kg) 50.268.0 (28.4–71.7) 50.668.7 (34.5–76.9) NA
DXA FM (kg) 34.2611.8 (8.8–74.4) 35.2613.3 (10.7–63.2) NA
BMI 28.866.4 (15.6–59.9) 29.267.1 (16.8–60.2) 33.167.9 (18.2–64.2)
DM2 n (%) 12 (5*) 12 (13) 113 (10)
MS n (%) 52 (21) 27 (27) 219 (19)
*p,0.02 compared to other groups.
doi:10.1371/journal.pone.0024017.t001
Table 2. Pearson partial correlation coefficients of
anthropometric variables and weight for the full DXA data set
(IG+CV=341 patients).
weight
age NS
height 0.29 (0.37)
waistline 0.86 (0.74)
hipline 0.76 (0.51)
Value in parentheses is the partial correlation coefficient, i.e., the correlation
between two variables with all other variables held constant; NS=non-
significant correlation.
doi:10.1371/journal.pone.0024017.t002
Table 3. Pearson partial correlation coefficients between
anthropometric variables and DXA-derived body
compartments for the full DXA data set (n=341).
fat mass trunk fat mass fat free mass
age NS NS (0.14) NS (20.26)
height 0.17 (NS) 0.13 (20.16) 0.42 (0.48)
waistline 0.84 (NS) 0.87 (0.35) 0.74 (0.29)
hipline 0.77 (0.33) 0.74 (NS) 0.62 (NS)
Values in parentheses are the partial correlation coefficients. Correlations #0.10
or with p.0.05 are considered non-significant (NS).
doi:10.1371/journal.pone.0024017.t003
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In this study, we have selected a subject population that is similar
in body weight and shape of typical North American females,
spanning a wide range of ages (15–80), BMI, and body shapes.
The predictive equations obtained are, therefore, valid only for
this specific population.
Estimates of body composition based on anthropometric
variables have a long history of research interest (reviewed by
[14]). Initial investigations were performed using restricted
populations for which the models performed well, but not
surprisingly, did not generalize to more diverse populations [18].
Subsequently, detailed studies confirmed the logical assumption
that anthropometric models are valid if the database employed for
analysis is diverse [19,20]. Earlier studies relied primarily on
isotope dilution and specific gravity (hydrostatic) measurements to
determine FM and FFM [21] and these did not determine regional
differences in fat mass and fat free mass. More recent studies used
newer technologies to determine body compartments, e.g., DXA,
CT, or MRI, that can also accurately determine regional tissue
composition, although with some clear differences among the
techniques [22]. Characteristics of regional fat distribution,
particularly of centripetal fat, have been identified as important
variables in the pathophysiology of metabolic disease and we have
modeled anthropometric variables to estimate those body
compartments.
Within the populations studied, a number of interesting
relationships between weight and body composition were
identified. First, FM and FFM are linearly related as a function
of weight, such that over a large range of weight, each kilogram is
composed of about 60% fat and 40% fat free mass. In contrast, an
earlier study using a female population consisting of body fat
percentages ranging from undernourished to obese, concluded
that the relationship between FM and FFM is a logarithmic one.
However, this previous study did not take into account
anthropometric variables such as height, age, or body shape
[23]. Further, if the outliers who were extremely underweight are
excluded from the analysis, logarithmic and linear relationships
between FM and FFM become very similar (data not shown). A
subsequent study extended the population to include men, but
assumed a logarithmic relationship between FM and FFM to
develop the model [10]. Neither compare well with the current
study, as shown in Figure 3A. In contrast, an anthropometric study
of an obese female population similar to ours [13] concluded that a
linear relationship exists between FM and FFM, although with a
shallower slope (0.4660.01 versus 0.5960.01 in the present study
respectively). The reason for this discrepancy is unclear, but could
Figure 1. Multiple linear regression models based upon DXA measurements obtained from the Index Group predict the
corresponding body masses in the Cross Validation group with good accuracy. A) Bland-Altman analysis of actual versus predicted Total
Fat has a very small average bias (i.e., the average of the differences between the two measurements) of 0.281 kg and a standard deviation of 3.44 kg
(heavy dashed lines indicate the limits of agreement (mean bias61.96 its standard deviation): 26.47 to 7.03 kg). B) Predicted Trunk Fat has an
average bias of 0.328 (CI: 24.223 to 4.89 kg). C) Predicted Fat Free Mass has a bias of 20.176 kg (CI: 26.49 to 6.14 kg). D) Total Mass (FM + FFM) has
an average bias of 0.672 kg (CI: 20.965 to 2.31 kg).
doi:10.1371/journal.pone.0024017.g001
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For example, different methodologies to determine body compo-
sition in obese women are not equivalent when each is compared
to the ‘‘gold standard’’ four compartment model [22].
Results of the present study also show that the relationship
between FM and FFM is such that as body-weight increases, the
contributions of FM and FFM eventually become approximately
equal. This has physiological relevance because resting metabolic
rate is proportional to FFM. Individuals of greater weight will have
a corresponding greater fat free mass and thus will be more likely
to lose weight while undergoing calorie restriction. Although
height and body shape correlated well with FFM, partial
correlation analysis shows that only the waistline is appreciably
correlated to FFM when the other variables are held constant. Age
was related to FFM inversely and to TF in a positive manner. The
lack of correlation of age with other anthropometric variables
suggests that there are other variables not accounted for by the
model, e.g., possibly age-related differences in metabolic rate.
Regional fat distribution did weakly correlate with FM as increases
in hipline were associated with greater FM. Not surprisingly, TF
was correlated with waistline and negatively with height.
A number of longitudinal studies have evaluated the use of
simple anthropometrics, e.g., waistline, waist-hip ratio, and others,
in populations to predict the risk of developing DM2 in the future
[24]. In our approach, we were interested in identifying
individuals within an overweight population that are likely to
have undiagnosed metabolic dysfunction at the time of screening.
Based on studies that have confirmed the importance of central fat
distribution for the development of metabolic dysfunction,
including DM2, we have used DXA-derived body composition
in logistic regression models to determine the probability of the
presence of disease. Beginning with the DXA data group, the
discrimination of the logistic function derived from DXA data is
quite good with an AUC of 0.78 (Figure 4A). This is superior to
the results of screening based on questionnaires and compares
reasonably well with population screening based on clinical data
obtained invasively. For example, the KORA survey carried out in
Austria used a variety of published DM2 screening questionnaires
which were administered to 1573 participants aged 55–74 and
DM2 established by oral glucose tolerance testing. The resulting
AUCs range from 0.61–0.67 [25]. In contrast, in the San Antonio
Heart study screening was based on a predictive model that
Figure 2. FM increases faster than FFM as a function of weight. Relationships between predicted body composition and weight (abscissa) to
DXA-determined values (ordinate) for the full DXA population (IG + CV) are linear and show that with increasing mass, TF and FFM increase at similar
rates which are less than for the total FM. Predicted weight is the sum of FFM and FM (see text for discussion).
doi:10.1371/journal.pone.0024017.g002
Table 4. Coefficients of the linear regression equations
predicting DXA body composition derived from the Index
Group DXA population (n=241).
b0 b1 b2 b3 b4 b5
fat mass (FM) 215.49 0.05 0.54 0.11 0 22.47
trunk fat (TF) 210.14 0.04 0.28 0 0.07 20.03
fat free mass (FFM) 13.96 20.08 0.41 20.09 0 7.04
Predicted DXA value=height (b0)+age (b1)+weight (b3)+hipline (b4)+wa istline
(b4)+b5.
doi:10.1371/journal.pone.0024017.t004
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0.84 [26]. Identification of DM2 or MS by use of other variables
that were collected invasively, e.g., hemoglobin A1c, do not
appear to improve the sensitivity of detecting disease. For example,
data from the Health Aging and Body Composition Study
provides AUCs ,0.7 when used for diagnosis of DM2 [27].
The inflection points of the ROCs in the current study are of
interest, as the steep slopes in the left portion of the curves show
that within the population a large fraction of individuals with DM2
can be identified using anthropometric linear models to estimate
body composition, without incurring an unacceptably high false
positive rate. For example, for the threshold corresponding to the
point of the curve identified by an asterisk in Figure 4A, 62.5% of
the individuals with DM2 are correctly characterized (15 of 24),
whereas only 14% of people without DM2 are incorrectly
identified as positive (45 of 317) and 86% of individuals without
disease are correctly identified, i.e., a sensitivity of 62.5 and a
specificity of 86 percent. Not surprisingly, the shape of the ROC
for logistic regression identifying individuals with either DM2 or
MS was less steep, as would be expected in an obese population in
which individuals with disease overlapped with others who are
more similar than different in their anthropometric characteristics.
Use of regression models to study the larger EP population
confirmed the relevance of this analytical approach. However, a
primary limitation of this study is that it is valid only in the
population evaluated. This group is not representative of a general
population, consisting as it does of mostly middle aged, Caucasian,
overweight females that have consulted an endocrinologist. On the
other hand, such a population would also be expected to be more
difficult to differentiate individuals with disease from normals, as
the subjects are more similar in their body characteristics than
individuals within a more heterogeneous population. The results of
this proof-of-concept investigation suggests that larger studies
performed using more generalized population databases could
lead to the development of simple screening tools to identify those
at high risk for metabolic dysfunction. The incorporation of other
non-invasive, easily and inexpensively obtained variables, e.g.,
previously-validated questionnaires, would likely improve the
sensitivity and specificity of the models. A final caveat is that this
model cannot predict future risk of DM or MS, but only the
likelihood that an individual presently has significant risk for
having disease. It is this utility that especially suggests that this
approach might be very useful in mass health screening scenarios.
Methods
In accordance with the Unites States Code of Federal
Regulations 7 C.F.R. 1 1c.101b4, this research is exempt from
review by an Institutional Review Board as it constitutes
‘‘Research, involving the collection or study of existing data,
Figure 3. The relationship between the model estimates of FFM and FM is linear. A) Body composition based on modeling DXA-derived
data of the full DXA population (IG + CV) using anthropometric variables exhibits a linear relationship between FM and FFM (red line). The
anthropometric model of Weltmann [13], derived from hydrostatic weighing in a similar obese female population, is similar (black line). In contrast,
data obtained by Forbes [23] for a female population using isotopic dilution methodology is non-linear (blue line). B) The FFM/FM ratio approaches
unity for body mass greater than 100 kg.
doi:10.1371/journal.pone.0024017.g003
Table 5. Body composition of the Cross Validation group is
predicted by the regression equations derived from the Index
Group.
FM TF FFM
mean difference*
(± SD)
20.28163.44 kg 20.32862.33 kg 0.17663.23 kg
95% CI of mean bias 20.98 to
0.42 kg
20.80 to
0.15 kg
20.48 to
0.83 kg
Correlation (r
2) 0.965 0.950 0.920
p value NS NS NS
*Mean of difference between predicted and actual masses. Statistical
significance determined by paired student’s t-test.
doi:10.1371/journal.pone.0024017.t005
Diabetes Screening Using Anthropometrics
PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24017documents, records, pathological specimens, or diagnostic speci-
mens, if these sources are publicly available or if the information is
recorded by the investigator in such a manner that subjects cannot
be identified, directly or through identifiers linked to the subjects.’’
The patient populations studied were drawn from an ambulatory,
general endocrinology and weight management practice. In-
formed consent was not obtained as all data were analyzed
retrospectively in an anonymous manner. The initial study
population consisted all females in the medical practice for whom
complete anthropometric data were available who underwent
DXA for a weight control-fitness program (n=341). A second
independent group consisted of all female patients in a single
general endocrine practice (EP) for whom full anthropometric data
were available. The patients were clinically stable and except for
diabetes and metabolic syndrome, did not have known active
diseases that potentially could affect body composition (e.g.,
uncorrected thyroid dysfunction). All data were collected by a
single investigator (RY) and were blinded as to personal identity
for data analysis. The DXA scanner utilized was a Delphi QDR
series (Hologic, Bedford, MA). Data included in this analysis
consisted of total body mass (TBM), total fat mass (FM), trunk
(abdominal) fat mass (TF), and fat free mass (FFM). Anthropo-
metric variables were obtained to the same level of precision as
likely would be obtained within a mass health screening
environment. Specifically, subjects were weighed to within
0.25 kg using a precision clinical balance while lightly clothed
and without footwear. Height was measured to within 0.25 cm
using a clinical stadiometer, waistline (circumference to 0.5 cm,
taken at the level of the umbilicus at the end of gentle expiration),
hipline (circumference at the level of the greater trochanter), and
age. Diagnosis of DM2 was based upon the criteria of the
American Diabetes Association [28] and MS was established
following the criteria of the National Cholesterol Program [3].
The group of 341 individuals who underwent DXA scanning
was randomly divided into a Cross-Validation group (CV; n=95)
and the remaining 246 subjects constituted an Index Group (IG).
Characteristics of the subject populations are summarized in
Table 1. A predictive model for DXA-derived body composition
of the IG was then generated using stepwise multiple regression
analysis using FM, TM, and FFM as dependent variables and
anthropometric measurements as independent variables. The
resulting multiple regression models were then applied to the
CV group to determine how well the IG regression equations
predicted DXA body composition of these individuals. Using the
DXA-derived body composition of the fulI (G + CV) group, a
stepwise nominal logistic regression model was also constructed to
predict the probability that an individual within the DXA data set
had metabolic disease. Following successful validation of the
models in the two groups, a final multiple regression model was
determined using the entire data set (n=341) to estimate body
composition and regional fat distribution of a larger female
population drawn from a general Endocrinology Practice (EP;
n=1153). Finally, these values were then used to generate a
stepwise nominal logistic regression model to predict the presence
of metabolic disease.
Figure 4. The receiver operating characteristics of a nominal logistical regression using DXA-derived body composition as
independent variables to estimate the probability of DM2 or either DM2 or MS in the full DXA population (IG + CV) show that a
large percentage of the diseased individuals can be identified without a high cost of a false positive diagnosis. A) The steep slope of
the initial portion of the curve to the inflection point (*) indicates that a high proportion of individuals with DM2 can be identifying using DXA-
derived FM and TF. Area under the curve is 0.78 with a standard error of 0.05 (24 subjects with DM2 and 327 without; p,0.0001). The 95% confidence
interval is 0.68 to 0.88. [Regression equation: risk of DM2=1/(1+e
2z), where z=1.9420.53(TF)+0.28(FM).] B) Similarly, the ROC for the detection of
either DM2 or MS also shows inflection points, consistent with sensitive detection of subjects with disease. The AUC is 0.7160.03 (103 subjects with
disease, 238 without; p,0.0001). The 95% confidence interval for the AUC is 0.64 to 0.77. [Regression equation: k=2.3220.24(TF)+0.09(FM)].
doi:10.1371/journal.pone.0024017.g004
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Cary, NC). Dependent variables were DXA-determined FM, TF,
and FFM. Independent variables were age, height, weight,
waistline, and hipline. The relationships between the independent
and dependent variables were examined for evidence of non-
linearity by calculating Pearson correlation coefficients for each
independent variable. Each variable was also transformed by
log10(x), 1/x, and squareroot (x). The observation that there were
no significant differences observed for the correlation coefficients
between the untransformed and transformed variables and the
dependent variables assured linearity. Of note, the results of prior
research examining anthropometric variables and body density-
derived fat and lean body masses have shown that there is no
significant curvilinearity between variables, confirming the appro-
priateness of the use of linear modeling [29]. Partial correlation
coefficients were calculated to estimate the correlation contributed
by each pair of variables when all other variables were held
constant. A comparison of actual versus predicted values was
accomplished using the Bland-Altman method [30] that deter-
mines bias (actual-predicted) as a function of the average of the
actual and predicted values estimated by two different methods.
Nominal logistic regression was performed to assess the sensitivity
and specificity of the diagnosis of DM2 or MS in the groups.
Probability values were calculated from a two-tailed distribution
and p,0.05 was considered significant.
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